Biomarkers such as carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 have the characteristics that enable them to detect the progression of CRC and gastrointestinal tumor at earlier stages (Duffy, 2001 ; Tanaka et al., 2010). This evidence concerns the gene CEACAM5 and digestive system neoplasm.